| Intratumoral heterogeneity and clonal evolution in liver cancer B Losic, AJ Craig, C Villacorta-Martin, SN Martins-Filho, N Akers, X Chen, ... Nature communications 11 (1), 291, 2020 | 264 | 2020 |
| Patient similarity network of newly diagnosed multiple myeloma identifies patient subgroups with distinct genetic features and clinical implications S Bhalla, DT Melnekoff, A Aleman, V Leshchenko, P Restrepo, J Keats, ... Science Advances 7 (47), eabg9551, 2021 | 59 | 2021 |
| Unannotated small RNA clusters associated with circulating extracellular vesicles detect early stage liver cancer J Von Felden, T Garcia-Lezana, N Dogra, E Gonzalez-Kozlova, ME Ahsen, ... Gut 71 (10), 2069-2080, 2022 | 40 | 2022 |
| Systematic pan-cancer analysis of somatic allele frequency L Spurr, M Li, N Alomran, Q Zhang, P Restrepo, M Movassagh, C Trenkov, ... Scientific reports 8 (1), 7735, 2018 | 23 | 2018 |
| RNA2DNAlign: nucleotide resolution allele asymmetries through quantitative assessment of RNA and DNA paired sequencing data M Movassagh, N Alomran, P Mudvari, M Dede, C Dede, K Kowsari, ... Nucleic acids research 44 (22), e161-e161, 2016 | 16 | 2016 |
| A three-gene signature predicts response to selinexor in multiple myeloma P Restrepo, S Bhalla, Y Ghodke-Puranik, A Aleman, V Leshchenko, ... JCO Precision Oncology 6, e2200147, 2022 | 12 | 2022 |
| Tumoral and immune heterogeneity in an anti-PD-1-responsive glioblastoma: a case study P Restrepo, R Yong, I Laface, N Tsankova, K Nael, G Akturk, R Sebra, ... Molecular Case Studies 6 (2), a004762, 2020 | 9 | 2020 |
| Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation M Elnaggar, S Agte, P Restrepo, M Ram, D Melnekoff, C Adamopoulos, ... Journal of Hematology & Oncology 15 (1), 109, 2022 | 5 | 2022 |
| Overexpressed somatic alleles are enriched in functional elements in Breast Cancer P Restrepo, M Movassagh, N Alomran, C Miller, M Li, C Trenkov, ... Scientific Reports 7 (1), 8287, 2017 | 4 | 2017 |
| GeTallele: A Method for Analysis of DNA and RNA Allele Frequency Distributions P Słowiński, M Li, P Restrepo, N Alomran, LF Spurr, C Miller, ... Frontiers in bioengineering and biotechnology 8, 1021, 2020 | 3 | 2020 |
| A temporal classifier predicts histopathology state and parses acute-chronic phasing in inflammatory bowel disease patients LA Peters, JR Friedman, A Stojmirovic, J Hagen, S Houten, T Dodatko, ... Communications Biology 6 (1), 95, 2023 | 2 | 2023 |
| Unannotated small RNA clusters in circulating extracellular vesicles detect early stage liver cancer J Von Felden, T Garcia-Lezana, N Dogra, E Kozlova, ME Ahsen, AJ Craig, ... bioRxiv, 2020.04. 29.066183, 2020 | 1 | 2020 |
| GeTallele: a method for integrative analysis and visualization of DNA and RNA allele frequencies P Słowiński, M Li, P Restrepo, N Alomran, LF Spurr, C Miller, ... bioRxiv, 491209, 2018 | 1 | 2018 |
| Correction: Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation M Elnaggar, S Agte, P Restrepo, M Ram, D Melnekoff, C Adamopoulos, ... Journal of Hematology & Oncology 16 (1), 52-52, 2023 | | 2023 |
| Gain of chr1q Portends Poor Outcomes in Multiple Myeloma Patients Treated with Venetoclax A Lagana, S Thibaud, DT Melnekoff, P Restrepo, V Leshchenko, ... Blood 140 (Supplement 1), 4388-4390, 2022 | | 2022 |
| P-090: BRAF V600E multiple myeloma patient salvaged with triple MAPK inhibition after CAR T relapse S Agte, M Elnaggar, C Adamopolous, D Melnekoff, A Adleman, K Kappes, ... Clinical Lymphoma Myeloma and Leukemia 21, S88, 2021 | | 2021 |
| Intra-tumoral epigenetic heterogeneity and aberrant molecular clocks in hepatocellular carcinoma P Restrepo, A Bubie, AJ Craig, I Labgaa, M Schwartz, S Thung, ... medRxiv, 2021.03. 22.21253654, 2021 | | 2021 |
| Regional DNA methylation profiling reveals novel epigenetic intra-tumoral heterogeneity signatures and aberrant molecular clocks in hepatocellular carcinoma A Bubie, P Restrepo, A Craig, I Labgaa, M Schwartz, S Thung, ... Cancer Research 80 (16_Supplement), 1507-1507, 2020 | | 2020 |
| Mapping tumoral and immune heterogeneity in PD-1 responsive glioblastoma P Restrepo, R Yong, I Laface, N Tsankova, S Gnjatic, A Hormigo, B Losic Cancer Research 79 (13_Supplement), 2528-2528, 2019 | | 2019 |
